Main Content start here
Main Layout
Report Description

Report Description

Forecast Period

2026-2030

Market Size (2024)

USD 252.34 Million

Market Size (2030)

USD 346.77 Million

CAGR (2025-2030)

5.40%

Fastest Growing Segment

Traumatic Brain Injury

Largest Market

North America

Market Overview

Global Acute External Ventricular Drain Market was valued at USD 252.34 Million in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 5.40% through 2030. The global healthcare industry has been witnessing a steady rise in the demand for neurosurgical procedures and devices, and one such critical device that plays a pivotal role in the management of patients with intracranial conditions is the Acute External Ventricular Drain (EVD). EVDs are indispensable tools for monitoring and managing cerebrospinal fluid (CSF) levels, intracranial pressure (ICP), and assisting in various neurosurgical procedures. The global Acute External Ventricular Drain market has been experiencing significant growth over the past few years and is expected to continue its upward trajectory. Key factors contributing to this growth include an aging population, increasing incidence of traumatic brain injuries, strokes, and various neurological disorders, as well as advancements in technology and healthcare infrastructure. The rising prevalence of neurological disorders such as hydrocephalus, traumatic brain injuries (TBI), intracerebral hemorrhages, and brain tumors is driving the demand for EVDs. The global population is aging, and elderly individuals are more susceptible to conditions that require neurosurgical interventions, thus boosting the demand for EVDs. Ongoing research and development in neurosurgery and medical devices have led to the introduction of more advanced and user-friendly EVDs, which are being adopted by healthcare facilities worldwide. Emerging economies are investing in healthcare infrastructure development, leading to increased access to advanced medical devices, including EVDs. Increasing awareness among patients and healthcare professionals about the importance of early diagnosis and treatment of neurological conditions has driven the demand for EVDs.

With the growing healthcare infrastructure in emerging markets, there are significant opportunities for EVD manufacturers to expand their presence and tap into underserved regions. Investing in research and development to create more advanced and safer EVD technologies can give companies a competitive edge. Collaborating with healthcare institutions and research organizations can help in the development and adoption of EVD technologies. Offering training programs for healthcare professionals in the proper use and maintenance of EVDs can enhance market penetration.

Key Market Drivers

Rising Incidence of Neurological Disorders  

The Global Acute External Ventricular Drain (EVD) Market has been experiencing steady growth in recent years, driven by a combination of factors that reflect the increasing prevalence of neurological disorders, advancements in medical technology, and a growing aging population. In 2021, over 3 billion individuals globally were affected by neurological conditions, underscoring a significant and growing healthcare challenge. The World Health Organization (WHO) played an active role in interpreting data from the Global Burden of Disease, Injuries, and Risk Factor Study (GBD) 2021, offering critical insights to inform strategic healthcare planning and investment decisions across both public and private sectors. EVD is a crucial medical device used in the management of conditions like hydrocephalus, traumatic brain injuries, and intracranial hemorrhage. In 2019, traumatic brain injury (TBI) accounted for 27.16 million new cases globally, with 48.99 million individuals living with the condition and 7.08 million years lived with disability (YLDs). In parallel, spinal cord injury (SCI) recorded 0.91 million new cases, 20.64 million prevalent cases, and 6.20 million YLDs. One of the primary drivers of the Global Acute EVD Market is the increasing incidence of neurological disorders worldwide. Neurological conditions, such as hydrocephalus, which involves the accumulation of cerebrospinal fluid in the brain, often require surgical intervention, including the use of EVDs. Additionally, traumatic brain injuries and intracranial hemorrhages, which can result from accidents or falls, necessitate immediate medical attention, leading to an increased demand for EVDs.

Traumatic brain injuries (TBIs) resulting from accidents, sports injuries, and other events have been on the rise. TBIs often require surgical interventions, including the use of EVDs to manage intracranial pressure and drain excess cerebrospinal fluid. Each year, injuries whether accidental or resulting from violence lead to 4.4 million deaths globally, representing nearly 8% of total mortality. Moreover, injuries and violence collectively account for approximately 10% of all years lived with disability (YLDs), placing a significant and measurable strain on global health systems, insurance frameworks, and workforce productivity. The surge in trauma cases has directly contributed to the increasing demand for EVDs in the medical sector. Awareness about the importance of early diagnosis and intervention in neurological disorders has been steadily increasing, both among healthcare professionals and the general public. As a result, more individuals are seeking medical attention for neurological symptoms, leading to higher diagnosis rates and EVD placement when necessary. Moreover, healthcare providers are continually improving their skills and knowledge in neurosurgical procedures, further driving the demand for EVDs.

Modern lifestyles characterized by sedentary habits, poor dietary choices, and high stress levels have contributed to the rise in neurological disorders like stroke, which can be caused or exacerbated by these factors. As the global population ages, the incidence of age-related neurological disorders such as Alzheimer's disease and Parkinson's disease has increased. With longer life expectancies, these conditions are becoming more prevalent. Over the past 25 years, the global prevalence of Parkinson’s disease (PD) has doubled, reflecting a sharp upward trend in neurodegenerative disorders. In 2019, more than 8.5 million individuals were living with PD. That same year, the disease was responsible for 5.8 million disability-adjusted life years (DALYs) an 81% increase since 2000 and 329,000 deaths, marking a surge of over 100% in mortality linked to PD.

Acute External Ventricular Drain (EVD) is a medical device used to manage patients with neurological conditions, primarily those suffering from hydrocephalus or traumatic brain injury (TBI). This life-saving procedure involves the insertion of a catheter into the brain's ventricles to drain excess cerebrospinal fluid (CSF), which can help reduce intracranial pressure and prevent further damage. Elevated intracranial pressure can lead to severe neurological complications. EVD helps maintain optimal pressure levels, preventing further damage to brain tissue. EVD allows healthcare providers to monitor the composition and volume of cerebrospinal fluid, enabling them to make informed decisions about the patient's treatment plan. EVD provides a route for the administration of medications directly into the cerebrospinal fluid, ensuring rapid and targeted treatment. As more individuals are diagnosed with neurological disorders, the number of patients requiring EVD treatment has also increased, leading to a higher demand for EVD devices.

Increasing Healthcare Expenditure 

Healthcare expenditure is on the rise worldwide, driven by factors such as an aging population, the increasing prevalence of chronic diseases, and advancements in medical technology. A 2021 report reveals that global health expenditure rose to USD9.8 trillion equivalent to 10.3% of global GDP marking continued growth during the second year of the pandemic. This uptick was primarily fueled by elevated government allocations and a notable rise in out-of-pocket health spending, reflecting sustained pressure on public finances and household budgets amid ongoing healthcare demands. One particular segment of the healthcare industry that is benefiting from this trend is the global acute external ventricular drain (EVD) market. EVDs are critical medical devices used in neurosurgery to treat conditions such as hydrocephalus, traumatic brain injuries, and intracranial hemorrhages. As healthcare spending continues to grow, the demand for EVDs is also increasing.

According to a joint analysis by Imperial College London and the World Health Organization, published in The Lancet, the global number of adults aged 30–79 living with hypertension has nearly doubled over the past three decades from 650 million to 1.28 billion. Alarmingly, close to 50% of these individuals remain undiagnosed. Chronic diseases like hypertension and diabetes can contribute to neurological conditions that require EVDs for treatment. The increasing incidence of these diseases further fuels the demand for EVDs. Emerging economies are investing heavily in healthcare infrastructure, expanding the availability of specialized medical facilities and neurosurgical services. This expansion facilitates easier access to neurosurgical procedures involving EVDs.

The global acute external ventricular drain market is benefiting significantly from the increasing healthcare expenditure worldwide. As healthcare systems evolve to meet the demands of an aging population and the rising prevalence of chronic diseases, the importance of EVDs in neurosurgery cannot be overstated. Technological advancements, greater awareness, and expanding healthcare infrastructure are all contributing to the market's growth. While the acute EVD market presents significant opportunities, it also faces challenges related to cost containment and regulatory compliance. Industry players must navigate these challenges while continuing to innovate and provide high-quality products to meet the growing demand for EVDs in neurosurgery.

Acute External Ventricular Drain Market

Download Free Sample Report

Key Market Challenges

Regulatory Compliance and Quality Assurance

One of the primary challenges in the EVD market is ensuring compliance with rigorous regulatory requirements and maintaining high-quality standards. These devices are critical for patient safety, and any flaws in design, manufacturing, or usage can have severe consequences. Manufacturers must adhere to strict guidelines set by regulatory bodies like the FDA and CE (Conformité Européene) in Europe. Ensuring compliance while striving for innovation is a delicate balance that EVD companies must navigate.

Cost Constraints

The cost of EVD devices can be a significant barrier for many patients and healthcare institutions. These devices are often complex and require precise engineering, which can make them expensive. Cost constraints can limit access to EVDs for patients in developing countries and strain the budgets of healthcare facilities in developed nations. Finding ways to reduce production costs without compromising quality is an ongoing challenge for manufacturers.

Infection Control

Infection control is a critical concern when it comes to EVDs. Inserting a foreign object into the brain carries the risk of infection, which can lead to serious complications. Healthcare providers must follow strict protocols to minimize this risk, including maintaining sterile environments during insertion and monitoring for signs of infection afterward. Advances in materials and techniques are continually being explored to reduce the likelihood of infection associated with EVDs.

Key Market Trends

Technological Advancements

The healthcare industry has witnessed remarkable transformations in recent years, largely driven by technological advancements that have revolutionized patient care, diagnosis, and treatment. One area where these advancements are making a significant impact is in the field of neurosurgery and critical care. The Global Acute External Ventricular Drain (EVD) Market is experiencing substantial growth due to the integration of cutting-edge technologies, making it an integral component of modern medical practice. Recent advancements in material science and engineering have led to the development of smaller, lightweight, and biocompatible EVD devices. Miniaturized EVDs offer several benefits, including reduced infection risk, ease of placement, and patient comfort. Additionally, these devices are less obtrusive, making them more patient-friendly while providing healthcare professionals with enhanced monitoring capabilities.

Wireless technology has brought a new dimension to EVD management. Modern EVD systems are equipped with wireless sensors and connectivity options that allow real-time monitoring and remote data access. This enables healthcare providers to closely monitor patients' ICP and CSF pressure without being physically present, making it especially valuable in telemedicine and remote patient management scenarios. Artificial intelligence (AI) and machine learning algorithms have made significant inroads in healthcare, including the neurosurgical field. AI-powered EVD systems can analyze vast amounts of data, providing insights into trends and patterns in ICP and CSF pressure. This data-driven approach allows for more precise prediction of critical events and timely interventions, potentially saving lives and improving patient outcomes. Infections associated with EVDs have been a long-standing concern. However, technological advancements have led to the development of EVDs with enhanced infection control features. Antimicrobial-coated catheters, closed drainage systems, and sterile insertion techniques have significantly reduced the risk of infections associated with EVD placement, improving patient safety.

Three-dimensional printing technology has revolutionized the manufacturing of medical devices, including EVDs. Customized EVDs tailored to individual patient anatomy are now possible, reducing the risk of complications and optimizing therapeutic outcomes. These personalized EVDs are designed to fit each patient's unique needs, enhancing precision in drainage and pressure monitoring. The global Acute External Ventricular Drain market is on a steady growth trajectory, driven by these technological advancements. As healthcare providers and institutions recognize the benefits of modern EVD systems in improving patient care and reducing the burden on healthcare resources, the demand for these devices continues to rise. Furthermore, as the world's population ages and the incidence of conditions requiring EVD placement increases, the market is poised for continued expansion. The integration of advanced technologies not only improves patient outcomes but also reduces healthcare costs by minimizing complications, optimizing treatment strategies, and shortening hospital stays.

Segmental Insights

Application Insights

Based on the application, the traumatic brain injury segment emerged as the fastest growing segment in the global market for Acute External Ventricular Drain Market in 2024. Traumatic Brain Injuries are a major public health concern globally. They can result from accidents, falls, sports injuries, or other forms of trauma. The high incidence of TBIs means that there is a substantial patient population in need of neurosurgical interventions like EVDs to manage intracranial pressure (ICP). EVDs are commonly used in neurosurgical and critical care settings to monitor and manage intracranial pressure. In cases of severe Traumatic Brain Injuries, one of the critical complications is elevated ICP, which can lead to secondary brain damage. EVDs are often used to drain cerebrospinal fluid (CSF) and control ICP, helping to mitigate this risk. While TBIs are a significant contributor, acute brain injuries can also result from other causes, such as subarachnoid hemorrhages, intracerebral hemorrhages, and infections like meningitis. However, TBIs tend to be more common and may result in more consistent demand for EVDs. Continuous research and advancements in neurosurgical techniques and EVD technology may expand the use of EVDs to manage various brain injuries. For example, new EVD designs and materials may enhance their effectiveness and reduce complications, making them suitable for a broader range of conditions. Clinical guidelines and protocols often recommend the use of EVDs in cases of severe TBI to monitor and manage ICP. This standardization of care practices can contribute to the dominance of EVDs in the TBI segment.

Acute External Ventricular Drain Market

Download Free Sample Report

Regional Insights

North America emerged as the largest market in the global Acute External Ventricular Drain market in 2024, holding the largest market share in terms of value. North America, particularly the United States and Canada, has a robust and advanced healthcare infrastructure. This includes a large number of hospitals, medical centers, and healthcare professionals who can diagnose and treat conditions that require the use of EVDs. This well-established healthcare system creates a substantial demand for medical devices like EVDs North America is home to many leading medical device companies and research institutions that focus on developing and innovating medical technologies. These organizations often receive substantial funding for research and development, which can result in the creation of new and improved EVD devices and technologies. The United States Food and Drug Administration (FDA) and Health Canada have rigorous but well-defined regulatory processes for medical devices. While this can create barriers to entry for some companies, it also ensures that products on the market meet high safety and efficacy standards. A strong regulatory framework can inspire confidence in both healthcare providers and patients, driving demand for EVDs from companies that meet these standards.

Recent Developments

  • In March 2025, Anuncia Medical, Inc., a front-runner in cerebrospinal fluid (CSF) management and neurocritical care, has secured FDA Breakthrough Device Designation for its ReFlow® EVD—an advanced system designed to optimize the use of external ventricular drains (EVDs) in managing cerebral edema and elevated intracranial pressure. This designation strengthens Anuncia’s expanding breakthrough device portfolio, building on the clinical track record of the ReFlow® System Mini—now in its sixth year of clinical application—and the early U.S. adoption of the ReFlow® Mini Flusher, which enables noninvasive, at-home CSF flow restoration and significantly reduces the incidence of costly surgical revisions. With the addition of ReFlow® EVD, Anuncia is strategically positioned to address both acute and chronic CSF challenges, further accelerating innovation and market penetration in the neurocritical care landscape.
  • In July 2023, Integra LifeSciences Holdings Corporation, a global leader in medical technology, has reported favorable clinical and economic outcomes associated with its Codman® Bactiseal® External Ventricular Drain (EVD) catheter set in treating hydrocephalus secondary to aneurysmal subarachnoid hemorrhage (aSAH). The findings stem from a real-world clinical study conducted at University Hospital Gemelli in Rome, Italy, supported by an independent research grant from Integra. The results—authored by Rina Di Bonaventura, Michele Basile, Alessandro Olivi, Americo Cicchetti, and Enrico Marchese—were published in the April 2023 issue of the Journal of Neurosurgical Sciences, one of Europe’s premier neurosurgery journals. The study reinforces both the clinical efficacy and cost-effectiveness of the Bactiseal® EVD system in high-acuity neurocritical care settings.

Key Market Players

  • Medtronic plc
  • Integra LifeSciences Corporation
  • Natus Medical Incorporated
  • Fuji Systems Corporation
  • Spiegelberg GmbH
  • SOPHYSA inc.
  • Neuromedex inc.

 By Application

By Patient Type

By Region

  • Traumatic Brain Injury (TBI)
  • Subarachnoid Hemorrhage
  • Intracerebral Hemorrhage
  • Others
  • Pediatric
  • Adult
  • North America
  • Europe
  • Asia Pacific
  • South America
  • Middle East & Africa

Report Scope:

In this report, the Global Acute External Ventricular Drain Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

  • Acute External Ventricular Drain Market, By Application:

o   Traumatic Brain Injury (TBI)

o   Subarachnoid Hemorrhage

o   Intracerebral Hemorrhage

o   Others

  • Acute External Ventricular Drain Market, By Patient Type:

o   Pediatric

o   Adult

  • Acute External Ventricular Drain Market, By Region:

o   North America

§  United States

§  Canada

§  Mexico

o   Europe

§  France

§  United Kingdom

§  Italy

§  Germany

§  Spain

o   Asia-Pacific

§  China

§  India

§  Japan

§  Australia

§  South Korea

o   South America

§  Brazil

§  Argentina

§  Colombia

o   Middle East & Africa

§  South Africa

§  Saudi Arabia

§  UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Acute External Ventricular Drain Market.

Available Customizations:

Global Acute External Ventricular Drain market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Acute External Ventricular Drain Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at sales@techsciresearch.com

Table of content

Table of content

1.    Product Overview

1.1.  Market Definition

1.2.  Scope of the Market

1.2.1.    Markets Covered

1.2.2.    Years Considered for Study

1.2.3.    Key Market Segmentations

2.    Research Methodology

2.1.  Objective of the Study

2.2.  Baseline Methodology

2.3.  Key Industry Partners

2.4.  Major Association and Secondary Sources

2.5.  Forecasting Methodology

2.6.  Data Triangulation & Validation

2.7.  Assumptions and Limitations

3.    Executive Summary

3.1.  Overview of the Market

3.2.  Overview of Key Market Segmentations

3.3.  Overview of Key Market Players

3.4.  Overview of Key Regions/Countries

3.5.  Overview of Market Drivers, Challenges, Trends

4.    Voice of Customer

5.    Acute External Ventricular Drain Market Outlook

5.1.  Market Size & Forecast

5.1.1.    By Value

5.2.  Market Share & Forecast

5.2.1.    By Application (Traumatic Brain Injury (TBI), Subarachnoid Hemorrhage, Intracerebral Hemorrhage, Others)

5.2.2.    By Patient Type (Pediatric, Adult)

5.2.3.    By Region

5.2.4.    By Company (2024)

5.3.  Market Map

6.    North America Acute External Ventricular Drain Market Outlook

6.1.  Market Size & Forecast       

6.1.1.    By Value

6.2.  Market Share & Forecast

6.2.1.    By Application

6.2.2.    By Patient Type

6.2.3.    By Country

6.3.  North America: Country Analysis

6.3.1.    United States Acute External Ventricular Drain Market Outlook

6.3.1.1.        Market Size & Forecast

6.3.1.1.1.           By Value

6.3.1.2.        Market Share & Forecast

6.3.1.2.1.           By Application

6.3.1.2.2.           By Patient Type

6.3.2.    Canada Acute External Ventricular Drain Market Outlook

6.3.2.1.        Market Size & Forecast

6.3.2.1.1.           By Value

6.3.2.2.        Market Share & Forecast

6.3.2.2.1.           By Application

6.3.2.2.2.           By Patient Type

6.3.3.    Mexico Acute External Ventricular Drain Market Outlook

6.3.3.1.        Market Size & Forecast

6.3.3.1.1.           By Value

6.3.3.2.        Market Share & Forecast

6.3.3.2.1.           By Application

6.3.3.2.2.           By Patient Type

7.    Europe Acute External Ventricular Drain Market Outlook

7.1.  Market Size & Forecast       

7.1.1.    By Value

7.2.  Market Share & Forecast

7.2.1.    By Application

7.2.2.    By Patient Type

7.2.3.    By Country

7.3.  Europe: Country Analysis

7.3.1.    Germany Acute External Ventricular Drain Market Outlook

7.3.1.1.        Market Size & Forecast

7.3.1.1.1.           By Value

7.3.1.2.        Market Share & Forecast

7.3.1.2.1.           By Application

7.3.1.2.2.           By Patient Type

7.3.2.    United Kingdom Acute External Ventricular Drain Market Outlook

7.3.2.1.        Market Size & Forecast

7.3.2.1.1.           By Value

7.3.2.2.        Market Share & Forecast

7.3.2.2.1.           By Application

7.3.2.2.2.           By Patient Type

7.3.3.    Italy Acute External Ventricular Drain Market Outlook

7.3.3.1.        Market Size & Forecast

7.3.3.1.1.           By Value

7.3.3.2.        Market Share & Forecast

7.3.3.2.1.           By Application

7.3.3.2.2.           By Patient Type

7.3.4.    France Acute External Ventricular Drain Market Outlook

7.3.4.1.        Market Size & Forecast

7.3.4.1.1.           By Value

7.3.4.2.        Market Share & Forecast

7.3.4.2.1.           By Application

7.3.4.2.2.           By Patient Type

7.3.5.    Spain Acute External Ventricular Drain Market Outlook

7.3.5.1.        Market Size & Forecast

7.3.5.1.1.           By Value

7.3.5.2.        Market Share & Forecast

7.3.5.2.1.           By Application

7.3.5.2.2.           By Patient Type

8.    Asia-Pacific Acute External Ventricular Drain Market Outlook

8.1.  Market Size & Forecast       

8.1.1.    By Value

8.2.  Market Share & Forecast

8.2.1.    By Application

8.2.2.    By Patient Type

8.2.3.    By Country

8.3.  Asia-Pacific: Country Analysis

8.3.1.    China Acute External Ventricular Drain Market Outlook

8.3.1.1.        Market Size & Forecast

8.3.1.1.1.           By Value

8.3.1.2.        Market Share & Forecast

8.3.1.2.1.           By Application

8.3.1.2.2.           By Patient Type

8.3.2.    India Acute External Ventricular Drain Market Outlook

8.3.2.1.        Market Size & Forecast

8.3.2.1.1.           By Value

8.3.2.2.        Market Share & Forecast

8.3.2.2.1.           By Application

8.3.2.2.2.           By Patient Type

8.3.3.    Japan Acute External Ventricular Drain Market Outlook

8.3.3.1.        Market Size & Forecast

8.3.3.1.1.           By Value

8.3.3.2.        Market Share & Forecast

8.3.3.2.1.           By Application

8.3.3.2.2.           By Patient Type

8.3.4.    South Korea Acute External Ventricular Drain Market Outlook

8.3.4.1.        Market Size & Forecast

8.3.4.1.1.           By Value

8.3.4.2.        Market Share & Forecast

8.3.4.2.1.           By Application

8.3.4.2.2.           By Patient Type

8.3.5.    Australia Acute External Ventricular Drain Market Outlook

8.3.5.1.        Market Size & Forecast

8.3.5.1.1.           By Value

8.3.5.2.        Market Share & Forecast

8.3.5.2.1.           By Application

8.3.5.2.2.           By Patient Type

9.    South America Acute External Ventricular Drain Market Outlook

9.1.  Market Size & Forecast       

9.1.1.    By Value

9.2.  Market Share & Forecast

9.2.1.    By Application

9.2.2.    By Patient Type

9.2.3.    By Country

9.3.  South America: Country Analysis

9.3.1.    Brazil Acute External Ventricular Drain Market Outlook

9.3.1.1.        Market Size & Forecast

9.3.1.1.1.           By Value

9.3.1.2.        Market Share & Forecast

9.3.1.2.1.           By Application

9.3.1.2.2.           By Patient Type

9.3.2.    Argentina Acute External Ventricular Drain Market Outlook

9.3.2.1.        Market Size & Forecast

9.3.2.1.1.           By Value

9.3.2.2.        Market Share & Forecast

9.3.2.2.1.           By Application

9.3.2.2.2.           By Patient Type

9.3.3.    Colombia Acute External Ventricular Drain Market Outlook

9.3.3.1.        Market Size & Forecast

9.3.3.1.1.           By Value

9.3.3.2.        Market Share & Forecast

9.3.3.2.1.           By Application

9.3.3.2.2.           By Patient Type

10. Middle East and Africa Acute External Ventricular Drain Market Outlook

10.1.             Market Size & Forecast        

10.1.1. By Value

10.2.             Market Share & Forecast

10.2.1. By Application

10.2.2. By Patient Type

10.2.3. By Country

10.3.             MEA: Country Analysis

10.3.1. South Africa Acute External Ventricular Drain Market Outlook

10.3.1.1.     Market Size & Forecast

10.3.1.1.1.         By Value

10.3.1.2.     Market Share & Forecast

10.3.1.2.1.         By Application

10.3.1.2.2.         By Patient Type

10.3.2. Saudi Arabia Acute External Ventricular Drain Market Outlook

10.3.2.1.     Market Size & Forecast

10.3.2.1.1.         By Value

10.3.2.2.     Market Share & Forecast

10.3.2.2.1.         By Application

10.3.2.2.2.         By Patient Type

10.3.3. UAE Acute External Ventricular Drain Market Outlook

10.3.3.1.     Market Size & Forecast

10.3.3.1.1.         By Value

10.3.3.2.     Market Share & Forecast

10.3.3.2.1.         By Application

10.3.3.2.2.         By Patient Type

11. Market Dynamics

11.1.   Drivers

11.2.   Challenges

12. Market Trends & Developments

12.1.   Recent Developments

12.2.   Product Launches

12.3.   Mergers & Acquisitions

13. Global Acute External Ventricular Drain Market: SWOT Analysis

14. Competitive Landscape

14.1.   Medtronic plc

14.1.1.       Business Overview

14.1.2.       Product & Service Offerings

14.1.3.       Recent Developments

14.1.4.       Financials (If Listed)

14.1.5.       Key Personnel

14.1.6.       SWOT Analysis

14.2.   Integra LifeSciences Corporation

14.3.   Natus Medical Incorporated

14.4.   Fuji Systems Corporation

14.5.   Spiegelberg GmbH

14.6.   SOPHYSA inc.

14.7.   Neuromedex inc.

15. Strategic Recommendations

16. About Us & Disclaimer

Figures and Tables

Frequently asked questions

Frequently asked questions

The market size of the Global Acute External Ventricular Drain Market was estimated to be USD 252.34 Million in 2024.

Regulatory Compliance and Quality Assurance and Cost Constraints are the major challenges which restrict the growth of the Global Acute External Ventricular Drain Market.

Medtronic plc, Integra LifeSciences Corporation, Natus Medical Incorporated, Fuji Systems Corporation, Spiegelberg GmbH were the top players operating in the Global Acute External Ventricular Drain Market in 2024.

Rising Incidence of Neurological Disorders and Increasing Healthcare Expenditure are the major drivers for the Global Acute External Ventricular Drain Market.

Related Reports

We use cookies to deliver the best possible experience on our website. To learn more, visit our Privacy Policy. By continuing to use this site or by closing this box, you consent to our use of cookies. More info.